Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL
On August 26, 2020, the U.S. Food and Drug Administration (FDA) announced that Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL and STIMATE® Nasal Spray 1.5 mg/mL listed at the website below as a Class I Recall. This recall is due to superpotency, or amounts of desmopressin in these medications higher than specified.
Your health and safety are important to us. If you are currently taking DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL or STIMATE® Nasal Spray 1.5 mg/mL, please contact your health care provider to discuss which other treatments or medicines made may be appropriate.
For more information, please visit https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ferring-us-issues-voluntary-nationwide-recall-ddavpr-nasal-spray-10-mcg01ml-desmopressin-acetate. You can also contact Ferring by phone at 1-888-FERRING (1-844-337-7464) option #2 (TTY 711), Monday through Friday, 8 a.m. to 5:30 p.m., Eastern Time (ET). In addition, you can call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), Monday through Friday, 8 a.m. to 6 p.m., and Saturday 8 a.m. to 4:30 p.m., ET.